Growth Ratio Summary

Growth Score : 8.00

Biocon demonstrates strong growth, driven by significant increases in revenue, operating profit, assets, and net income. This indicates successful strategic initiatives and market penetration. However, the negative EPS growth suggests that profitability on a per-share basis needs improvement. Sustaining this growth momentum while enhancing profitability will be key to long-term success.

Financial Ratio Summary

Financial Score : 6.80

Biocon's financial ratios indicate a mixed performance. Strong book value per share and capital expenditure management are offset by lower adjusted EPS and the absence of dividends. While cash earnings per share are positive, the lack of dividend payments may affect investor sentiment. Balancing these factors is crucial for maintaining a healthy financial profile.

Profitability Ratio Summary

Profitability Score : 4.70

Biocon's profitability ratios present a mixed picture. While the gross profit margin and operating margin are strong, returns on capital employed, equity, and assets are low. This indicates challenges in converting sales into profits and efficiently utilizing resources. Enhancing these returns is essential for improving overall financial performance and attracting investors.

Efficiency Ratio Summary

Efficiency Score : 2.50

Biocon's efficiency ratios suggest areas of concern in asset management and operational effectiveness. Low turnover ratios and extended receivable days indicate potential difficulties in converting sales into cash and managing inventory. Addressing these inefficiencies is crucial for improving profitability and optimizing resource utilization. Efficient asset management can enhance overall financial performance and shareholder value.

Coverage Ratio Summary

Coverage Score : 10.00

Biocon's coverage ratios reflect a strong capacity to meet its interest obligations, providing a cushion against financial stress. This indicates financial stability and creditworthiness. Maintaining these strong coverage metrics ensures the company can comfortably handle its debt obligations and attract favorable financing terms.

Solvency Ratio Summary

Solvency Score : 10.00

Biocon exhibits strong solvency, indicating a robust capability to meet its long-term debt obligations. The company's debt management and equity position contribute to its financial stability. This provides a solid foundation for future growth and expansion. A balanced approach to debt and equity ensures sustained financial health and investor confidence.

Liquidity Ratio Summary

Liquidity Score : 0.00

The company's liquidity position is concerning due to its inability to meet the thresholds. This suggests potential difficulties in meeting short-term obligations. The consistently low liquidity ratios may deter investors concerned about the company's immediate financial stability. Monitoring and improving these ratios are vital for maintaining operational efficiency and investor confidence.